Co-Doped Rare Earth Silicate Scintillation Crystal for Stable Fast Decay
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Commercial production of lutetium oxyorthosilicate scintillation crystals with good decay times and stable growth is challenging due to instability caused by high concentrations of Group 2 elements like calcium, leading to increased viscosity, reduced surface tension, and decreased heat transfer, resulting in spiral formation and microcracks.
Innovation Solution
Control the concentration of Group 2 elements such as calcium and magnesium within a specific range and maintain a controlled ratio with the activator to stabilize crystal growth, allowing for the production of commercially viable boules with no or very low spirals and decay times of no greater than 40 ns.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Loss of time
If high concentrations of Group 2 elements like calcium are used in the scintillation crystal, then decay time is reduced, but crystal growth stability deteriorates due to increased viscosity, reduced surface tension, and decreased heat transfer
Solution Approach 1:
The patent applies parameter changes by precisely controlling the concentration of Group 2 elements (calcium, magnesium) within specific ranges (calcium: 5-200 ppm, magnesium: 5-200 ppm) and maintaining controlled ratios with the activator (0.1-2.0 for Ca/Ce, 0.1-2.5 for Mg/Ce). This optimization balances the competing requirements of achieving short decay times (≤40 ns) while maintaining crystal growth stability, avoiding the harmful effects of high concentrations such as increased viscosity and reduced surface tension.
2Measurement precision
If high concentrations of Group 2 elements are used to achieve short decay times, then timing precision is improved, but spiral formation and microcracks increase
Solution Approach 1:
The patent optimizes parameter ranges to achieve timing precision while maintaining crystal quality. By controlling Group 2 element concentrations (Ca: 5-200 ppm, Mg: 5-200 ppm) and their ratios with activators, the patent achieves decay times ≤40 ns without causing spiral formation or microcracks that would compromise crystal reliability.
Solution Approach 2:
The patent employs co-doping with multiple elements (activator + Group 2 elements) to create a composite doped structure. This composite approach allows the synergistic effect of different dopants to achieve short decay times while the controlled composition prevents crystal defects, thereby improving both timing precision and crystal reliability simultaneously.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The controlled doping approach enables the production of large, high-quality scintillation crystals with improved decay times and reduced spiral formation, suitable for applications requiring precise timing, such as medical imaging.
Implementation Method 1
Lutetium oxyorthosilcates are commonly used in medical imaging radiation detectors
Data Source
Figure 1~2
Figure 3
Figure 4
AI summary
A scintillation crystal can include a rare earth silicate, an activator, and a Group 2 co-dopant. In an embodiment, the Group 2 co-dopant concentration may not exceed 200 ppm atomic in the crystal or 0.25 at% in the melt before the crystal is formed. The ratio of the Group 2 concentration/activator atomic concentration can be in a range of 0.4 to 2.5. In another embodiment, the scintillation crystal may have a decay time no greater than 40 ns, and in another embodiment, have the same or higher light output than another crystal having the same composition except without the Group 2 co-dopant. In a further embodiment, a boule can be grown to a diameter of at least 75 mm and have no spiral or very low spiral and no cracks. The scintillation crystal can be used in a radiation detection apparatus and be coupled to a photosensor.